Janugliflozin Tablets 50 mg (Sitagliptin Hydrochloride Monohydrate)
Sitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Youngpoong Pharmaceutical Co., Ltd.
MFDS item code 202004037 · Approved 2020.05.29
This product's status changed to Expired on 2025.05.29. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used in conjunction with dietary and exercise therapy to help control blood sugar levels in patients with type 2 diabetes. Initially administered alone, it can be used in combination with metformin if blood sugar control is insufficient. It can also be administered alongside sulfonylureas, metformin, thiazolidinediones, or insulin when monotherapy is ineffective. In cases where controlling blood sugar is difficult with multiple medications, this drug can be added to enhance therapeutic effects. It is used flexibly in various situations to improve blood sugar control in patients.
This medicine is administered at 100 mg once daily as monotherapy or in combination therapy, with a maximum daily dose of 100 mg. It may be taken with or without food. When coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Patients with renal impairment Since dose adjustment is required according to renal function, assessment of renal function is recommended before treatment with this medicine and periodically thereafter. 1. No dose adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is required in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. The dose for patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2) is 50 mg once daily. 4. The dose for patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2) is 25 mg once daily. This medicine may be administered regardless of the timing of dialysis.
This drug may cause allergic reactions; if symptoms such as skin rash or difficulty breathing occur during use, discontinue immediately and consult a physician. This medication can cause serious inflammation of the pancreas known as pancreatitis; if symptoms such as abdominal pain, vomiting, or loss of appetite occur, inform medical staff immediately. This medication should not be used in patients with type 1 diabetes or diabetic ketoacidosis, and it should not be administered to individuals with hypersensitivity to the drug or components. Patients with impaired kidney function may need dose adjustments for this medication, particularly those with low glomerular filtration rates or requiring dialysis should follow a doctor's instructions. There is a risk of hypoglycemia when taking this medication; if taken with insulin or sulfonylureas, it is important to monitor blood sugar levels frequently and adjust dosages as needed. If severe joint pain or skin blisters develop during use, stop taking the medication immediately and seek medical attention. Use during pregnancy or breastfeeding is not recommended, especially breastfeeding mothers should avoid taking this medication. Elderly individuals may experience decreased kidney function, so renal function should be assessed before taking this medication, and dosage adjustments may be necessary. In case of overdose, seek medical attention immediately for appropriate treatment, as some can be removed through hemodialysis; it is important to inform medical personnel.
Anaphylaxis, angioedema, Stevens-Johnson syndrome, acute pancreatitis, hypoglycemia, upper respiratory tract infection, nasopharyngitis, headache, diarrhea, abdominal pain, nausea, constipation, vomiting, severe and disability-associated arthralgia, vesicular pemphigoid, myalgia, limb pain, back pain, interstitial lung disease, pruritus, thrombocytopenia, rhabdomyolysis, elevated liver enzyme levels, acute renal failure, pneumonia, diabetes complications, metabolic acidosis, falls, cardiac arrest, dyspepsia, dizziness, increased blood triglycerides, gastritis, weight loss, hypertension, hypernatremia, erectile dysfunction
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air ingress and kept at room temperature between 1 and 30 degrees Celsius. Proper storage maintains the drug's efficacy and safety.
Pale orange, round, biconvex, film-coated tablet
28 tablets/patty [14 tablets/patty * 2]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Sitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Youngpoong Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Korea United Pharm., Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 28.35mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.